Education Day Presentations
The presentations made during AAMAC's 2013 Education Day are now posted on-line for viewing.
Go to the presentations.
New Clinical Trial for MDS Patients
Are you a patient with lower IPSS risk MDS with a hemoglobin level <100 but not yet transfusion dependent?
You may be eligible for a clinical trial of erythropoietin (EPO) plus deferasirox (DFX) for the improvement of hemoglobin
levels, which is currently enrolling at 3 Canadian centres.
Read the details here.
Don't Forget to Get the Flu Shot
Seasonal influenza can result in very serious illness or death, especially in people with bone marrow failure.
Vaccination reduces the risk of infection and the severity of symptoms, but is not recommended for all bone marrow failure
patients. Please check with your haematologist to see if vaccination is the right choice for you. Family members of bone marrow
failure patients can do their part by getting vaccinated themselves, to reduce the risk of
bringing influenza home to their vulnerable loved one. For more information on influenza and the flu vaccine,
click on the image below.
New Pediatric Research Grant Announced
The Aplastic Anemia and Myelodysplasia Association of Canada has partnered with the C17 Research Network to
fund scientific medical research on bone marrow failure in the pediatric community.